Aspiration & Biopsy Needles Market 2022 Outlook, Current and Future Industry Landscape Analysis 2032

  • By 2026, the global aspiration and the biopsy needle are estimated to reach US$ 1.29 billion.
  • Core needle biopsy (CNB) is the most common type of biopsy, accounting for over 47% of the total aspiration and biopsy needle market in 2019.
  • Hospitals accounted for 74.3% of the entire aspiration and biopsy needle market in 2019.
  • North America is the world’s largest consumer area, accounting for 35.2% of worldwide aspiration and biopsy needle market sales in 2019.
  • Europe is a significant consumer aspiration and biopsy needle market, accounting for 30.46% of worldwide sales.
  • Vacuum-assisted biopsy, biopsy guns, and biopsy forceps and punches will all develop at far faster rates than Fine Needle Aspiration, with CAGRs of 3.97 percent, 3.70 percent, and 1.63 percent, respectively.
Publicado en SEO en octubre 25 at 11:00
Comentarios (0)
No login
Inicie sesión o regístrese para enviar su comentario
Cookies on De Gente Vakana.
This site uses cookies to store your information on your computer.